Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis
Xu Yan, Xin-Yi Liu, Dian Zhang, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2344-2357
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 94
Applications of synthetic biology in medical and pharmaceutical fields
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
Haojie Chen, Pengyu Lei, Hao Ji, et al.
Materials Today Bio (2023) Vol. 18, pp. 100543-100543
Open Access | Times Cited: 50
Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis
Han Liu, Hao Zhang, Sicheng Wang, et al.
Composites Part B Engineering (2023) Vol. 255, pp. 110610-110610
Closed Access | Times Cited: 47
Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development
Ninglin Zhao, Yingjie Song, Xiangqian Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 37
Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment
Jiaoying Lu, Xinyuan Shen, Hongjun Li, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 13
Engineered probiotics
Junheng Ma, Yuhong Lyu, Xin Liu, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 59
ProbioticEscherichia coliNISSLE 1917 for inflammatory bowel disease applications
Zejing Zhao, Shumin Xu, Wangyang Zhang, et al.
Food & Function (2022) Vol. 13, Iss. 11, pp. 5914-5924
Closed Access | Times Cited: 57
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
Mengfan Li, Lijiao Yang, Chenlu Mu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2402-2414
Open Access | Times Cited: 51
Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy
Han Liu, Zhen Geng, Jiacan Su
Extracellular Vesicles and Circulating Nucleic Acids (2022) Vol. 3, Iss. 1, pp. 63-86
Open Access | Times Cited: 48
Next-Generation Probiotics for Inflammatory Bowel Disease
Marcella Pesce, Luisa Seguella, Alessandro Re, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5466-5466
Open Access | Times Cited: 40
Triggerable Prodrug Nanocoating Enables On-Demand Activation of Microbial and Small-Molecular Therapeutics for Combination Treatment
Xiao Kuang, Ying Liu, Huilong Luo, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 49, pp. 26932-26946
Closed Access | Times Cited: 23
Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications
Mingjing Yu, Shilong Hu, Biao Tang, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108202-108202
Open Access | Times Cited: 22
Versatile biomimetic nanomedicine for treating cancer and inflammation disease
B. Zhao, Dangge Wang, Yaping Li
Medical Review (2023) Vol. 3, Iss. 2, pp. 123-151
Open Access | Times Cited: 20
Macroencapsulated bacteria for in vivo sensing and therapeutics
Yidan Lyu, Hao Huang, Yuyan Su, et al.
Matter (2024) Vol. 7, Iss. 4, pp. 1440-1465
Closed Access | Times Cited: 9
Genetically Engineered Microorganisms and Their Impact on Human Health
Marzie Mahdizade Ari, Leila Dadgar, Z Yad Elahi, et al.
International Journal of Clinical Practice (2024) Vol. 2024, pp. 1-38
Open Access | Times Cited: 9
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Spase Stojanov, Aleš Berlec
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis
Tao Zhang, Yuzhu Chen, Xiaoang Li, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 7
Bacteria-based drug delivery for treating non-oncological diseases
Zhenping Cao, Yan Pang, Jun Pu, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 668-683
Closed Access | Times Cited: 6
Advanced probiotics: bioengineering and their therapeutic application
Tamanna Parvin, Sudha Rani Sadras
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 6
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Administration of a Next‐Generation Probiotic Escherichia coli Nissle 1917‐GLP‐1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes
Jie Luo, Yilin Fang, Zhanghua Qi, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2025) Vol. 2025, Iss. 1
Open Access
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics
A. Chen, Ying Gong, S. C. Wu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Haokun Shen, Zitong Zhao, Zengjue Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 594-594
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top